ORIC
Oric Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+27.08%
vs ±44.4% implied · ×0.61
shaded = implied · ▲▼ = realized
Oric Pharmaceuticals, Inc.
9.38
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Nextech InvestNextech Invest | $77.6M | 5.77% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $73.9M | 5.50% | +14.03% | |
| 3 | EcoR1 CapitalEcoR1 Capital | $72.9M | 5.42% | 0.00% | |
| 4 | T. Rowe Price AssociatesT. Rowe Price | $71.7M | 5.33% | +22.83% | |
| 5 | Viking Global InvestorsViking Global Investors | $55.5M | 4.13% | −11.98% | |
| 6 | State StreetState Streetindex-like | $53.0M | 3.95% | +32.19% | |
| 7 | SR One Capital ManagementSR One | $50.0M | 3.72% | +2.22% | |
| 8 | VR AdviserVR Adviser | $46.8M | 3.48% | 0.00% | |
| 9 | NEA ManagementNEA | $44.6M | 3.32% | 0.00% | |
| 10 | Vanguard Capital ManagementVanguardindex-like | $42.8M | 3.19% | +7.16% | |
| 11 | AIHC Capital ManagementAIHC | $41.5M | 3.09% | +55.66% | |
| 12 | Alkeon Capital ManagementAlkeon | $40.5M | 3.01% | −16.98% | |
| 13 | Column GroupColumn | $38.3M | 2.85% | 0.00% | |
| 14 | SirenSiren | $32.5M | 2.42% | 0.00% | |
| 15 | FMRFMR | $28.5M | 2.12% | +8.27% | |
| 16 | Citadel AdvisorsCitadel | $28.4M | 2.11% | +7.75% | |
| 17 | Goldman Sachs GroupGoldman Sachs | $26.6M | 1.98% | +66.14% | |
| 18 | Geode Capital ManagementGeodeindex-like | $22.6M | 1.69% | +13.67% | |
| 19 | First Turn ManagementFirst Turn | $21.8M | 1.63% | 0.00% | |
| 20 | Orbimed AdvisorsOrbimed | $21.8M | 1.62% | −25.20% | |
| 21 | Integral Health Asset ManagementIntegral Health | $20.6M | 1.53% | +35.71% | |
| 22 | MPM Oncology Impact ManagementMPM Oncology Impact | $20.4M | 1.52% | +4.34% | |
| 23 | Vivo CapitalVivo Capital | $20.0M | 1.49% | 0.00% | |
| 24 | Dimensional Fund AdvisorsDimensional | $19.5M | 1.45% | +22.44% | |
| 25 | Franklin ResourcesFranklin Resources | $19.5M | 1.45% | +23.72% |
180 managers report $1.3B of Oric Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 31 of them hold 80% of it; Nextech Invest is largest at 5.77%.
Expected move
No implied move.
No implied move.
No implied move.